Your Shopping Cart Is Empty
| Report Code: A10293 | Pages: 225 | Feb 2021 | 5361 Views | ||
| Author(s) : Sagar M, Sushant T , Onkar S | Tables: 22 | Charts: 19 |
| |
Note: Kindly use your official company email id in the form below for better and quick communication.
Also, Please note we do not send marketing emails to you unless you subscribed to for the news settlers, promotion etc.
Loading Table Of Content...
Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with hydrochlorothiazide and amlodipine for treatment of hypertension and cardiovascular risk reduction. It is available in different strengths tablets such as 20 mg, 40 mg, and 80 mg.
The utilization of telmisartan drug has witnessed significant growth, owing to surge in incidence of hypertension and cardiovascular diseases worldwide. Furthermore, other factors such as rise in geriatric population suffering from high blood pressure, surge in generic telmsartan tablets approvals, surge in awareness related to complication of hypertension, and sedentary lifestyle are the factors that fuel the growth of the market. However, drug shortages are expected to restrain the growth of the telmisartan market.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
